I’ve been a shareholder for a number of years and have a very different view than you, in fact it’s chalk & cheese. I can’t understand how you could come to the view that you stated, albeit a “one liner”.
The following is evidence of “walk”...
- 4 clinical trials about to commence
- Trials paid by Cannvalate, very modest cost to IHL
- Strong balance sheet, no debt
- Revenue growing from CBD oils sales and connected to the largest script provider in Australia
- Management with significant equity and so aligned to shareholders
- Dr Agarwal with performance milestones that are aligned to shareholders
Hopefully you find another winner. Probably need to buy a bell as well.
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-265
-
-
- There are more pages in this discussion • 19,933 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online